Bir Covid-19 Hastasında Hayatı Tehdit Eden Nadir Bir Mantar Enfeksiyonu

Öz

PP1D: JAMR-1046-4326-46 I am reporting a case of an emerging fungal infection, known as invasive/disseminated trichosporonosis, caused by trichosporon asahii, in a Covid-19 patient. After MEDLINE Database, Google Scholar, and PubMed search, I found this to be the first case reported in Saudi Arabia, in a Covid-19 patient. This patient had multiple risk factors, including diabetes mellitus, chronic kidney disease, prolonged intubation, central line/dialysis catheter, an arterial line, need for nasogastric tubes, antibiotics, corticosteroids, cardiovascular disease, last but not the least, Covid-19 itself. This patient continued to deteriorate, despite being on antifungal medications, and developed multi-organ failure, leading to mortality.

Anahtar Kelimeler

• COVID-19 virüs
• invaziv fungal enfeksiyonlar
• trikosporon

A rare life threatening fungal infection in a covid-19 patient

Öz

I am reporting a case of an emerging fungal infection, known as invasive/disseminated trichosporonosis, caused by trichosporon asahii, in a Covid-19 patient. After MEDLINE Database, Google Scholar, and PubMed search, I found this to be the first case reported in Saudi Arabia, in a Covid-19 patient. This patient had multiple risk factors, including diabetes mellitus, chronic kidney disease, prolonged intubation, central line/dialysis catheter, an arterial line, need for nasogastric tubes, antibiotics, corticosteroids, cardiovascular disease, last but not the least, Covid-19 itself. This patient continued to deteriorate, despite being on antifungal medications, and developed multi-organ failure, leading to mortality.

Anahtar Kelimeler

• COVID-19 virus
• invasive fungal Infections
• trichosporon

Kaynakça

1. 1. Calabrese F., Pezzuto F., Fortarezza F.et al., Hofman P., Kern I., Panizo A., Jan von der Thusen., Sergei Timofeev., Gregor Gorkiewics., Francesca Lunardi., Pulmonary pathology and COVID-19: lessons from the autopsy. The experience of European Pulmonary Pathologists. Virchows Archiv.359-372(2020) [PMC free article] [PubMed] [Google Scholar]
2. 2. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Elsevier B.V.; 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. International Journal of Antimicrobial Agents.Int J Antimicrob Agents. 105924 [PMC free article] [PubMed] [Google Scholar]
3. 3. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y.et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507–513. [PMC free article] [PubMed] [Google Scholar]
4. 4. Rodriguez-Tudela J.L., Alastruey-Izquierdo A., Gago S., Cuenca-Estrella M., León C., Miro J.M., A Nunez Boluda., I Ruiz Camps., A Sole., D W Denning., Burden of serious fungal infections in Spain. Clin Microbiol Infect. 2015; 21:183–189. [PubMed] [Google Scholar]
5. 5. de Almeida J.N., Hennequin C. Frontiers Media S.A.; 2016. Invasive trichosporon infection: a systematic review on a re-emerging fungal pathogen. Frontiers in Microbiology, Front Microbiol.2016.01629 [PMC free article] [PubMed] [Google Scholar]
6. 6. Lu Q.-B., Jiang W.-L., Zhang X., Li H.-J., Zhang X.-A., Zeng H.-L., Yang G.-L., Rui Li., Fang Li-Qun., Hao Li., Wei Liu., Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study. J Infect. 2020:159-198. [PMC free article] [PubMed] [Google Scholar]
7. 7. Song G., Liang G., Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from china. Mycopathologia. 2020;185:599–606. [PMC free article] [PubMed] [Google Scholar]
8. 8. Chagas-Neto T.C., Chaves G.M., Colombo A.L. Update on the genus trichosporon. Mycopathologia. 2008;166:121–132. [PubMed] [Google Scholar]

9. 9. Walsh T.J., Groll A., Hiemenz J., Fleming R., Roilides E., Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. 2004;10:48–66. [PubMed] [Google Scholar]
10. 10. Kontoyiannis D.P., Torres H.A., Chagua M., Hachem R., Tarrand J.J., Bodey G.P., Issam I Raad., Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004;36:564–569. [PubMed] [Google Scholar]
11. 11. Liao Y., Lu X., Yang S., Luo Y., Chen Q., Yang R. Epidemiology and outcome of Trichosporon Fungemia: a review of 185 reported cases from 1975 to 2014. Open Forum Infect Dis. 2015;2:10.ofv141 [PMC free article] [PubMed] [Google Scholar]